Literature DB >> 6886969

Comparative pharmacokinetics of caffeine in young and elderly men.

J Blanchard, S J Sawers.   

Abstract

The pharmacokinetic behavior of caffeine was compared in a group of eight healthy young men aged 20.5 +/- 2.0 years (mean +/- SD), and in a group of eight healthy, elderly men aged 71.2 +/- 3.9 years. Each subject was given a 5 mg/kg dose of caffeine as either an aqueous oral solution or an intravenous infusion over 30 min using a randomized crossover design. Plasma and urine samples were collected for 24 hr following each dose and analyzed for caffeine content using high-performance liquid chromatography. The peak times (tmax), peak concentrations (Cmax), and the percentage of the peroral dose systemically available, F(%), were essentially identical in both age groups, indicating that caffeine was absorbed rapidly and completely after peroral administration. These results also indicated that the first-pass metabolism observed in rats following the peroral administration of caffeine does not occur in either human group studied here. The elimination of caffeine during its terminal disposition phase was log-linear. Several between-group comparisons of other pharmacokinetic parameters were made. Although the average elimination rate constant was greater in the elderly, the difference did not reach statistical significance, possibly because of the considerable intersubject variability in the elimination rate of caffeine, with half-lives ranging from 2.27 to 9.87 hr. The average apparent volume of distribution was significantly lower in the elderly subjects while the clearances were slightly, but not significantly, larger in the elderly subjects. It appears that most aspects of the pharmacokinetic behavior of caffeine are very similar in young and elderly men.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886969     DOI: 10.1007/bf01061844

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  29 in total

1.  Anatomy of body water and electrolytes.

Authors:  I S EDELMAN; J LEIBMAN
Journal:  Am J Med       Date:  1959-08       Impact factor: 4.965

2.  Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene.

Authors:  A Aldridge; W D Parsons; A H Neims
Journal:  Life Sci       Date:  1977-10-01       Impact factor: 5.037

3.  Rapid gas chromatographic determination of underivatized theophylline in whole blood.

Authors:  M Sheehan; P Haythorn
Journal:  J Chromatogr       Date:  1976-02-18

4.  Normalization in the fitting of data by iterative methods. Application to tracer kinetics and enzyme kinetics.

Authors:  J H Ottaway
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

5.  Pharmacodynamic principles of drug therapy in the aged.

Authors:  A D Bender
Journal:  J Am Geriatr Soc       Date:  1974-07       Impact factor: 5.562

6.  Caffeine disposition and effects in young and one-year old rats.

Authors:  R Latini; M Bonati; E Marzi; M T Tacconi; B Sadurska; A Bizzi
Journal:  J Pharm Pharmacol       Date:  1980-08       Impact factor: 3.765

7.  Third international caffeine workshop.

Authors: 
Journal:  Nutr Rev       Date:  1981-04       Impact factor: 7.110

8.  Improved liquid-chromatographic determination of caffeine in plasma.

Authors:  J Blanchard; J D Mohammadi; K A Conrad
Journal:  Clin Chem       Date:  1980-08       Impact factor: 8.327

9.  The effect of vitamin C on the pharmacokinetics of caffeine in elderly men.

Authors:  J M Trang; J Blanchard; K A Conrad; G G Harrison
Journal:  Am J Clin Nutr       Date:  1982-03       Impact factor: 7.045

10.  Effects of age and other drugs on benzodiazepine kinetics.

Authors:  D J Greenblatt; R I Shader
Journal:  Arzneimittelforschung       Date:  1980
View more
  26 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake.

Authors:  Michael E Rybak; Maya R Sternberg; Ching-I Pao; Namanjeet Ahluwalia; Christine M Pfeiffer
Journal:  J Nutr       Date:  2015-02-04       Impact factor: 4.798

3.  A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects.

Authors:  G Yu; V Maskray; S H Jackson; C G Swift; B Tiplady
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

4.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

6.  Predicted metabolic drug clearance with increasing adult age.

Authors:  Thomas M Polasek; Farhaan Patel; Berit P Jensen; Michael J Sorich; Michael D Wiese; Matthew P Doogue
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

7.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

8.  Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease.

Authors:  Punitha Arasaratnam; Masoud Sadreddini; Yeung Yam; Vinay Kansal; Sharmila Dorbala; Marcelo F Di Carli; Rob S Beanlands; Michael E Merhige; Brent A Williams; Emir Veledar; James K Min; Li Chen; Terrence D Ruddy; Guido Germano; Daniel S Berman; Leslee J Shaw; Benjamin J W Chow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-27       Impact factor: 9.236

9.  Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed.

Authors:  Christopher Drake; Timothy Roehrs; John Shambroom; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

10.  Does long-term coffee intake reduce type 2 diabetes mellitus risk?

Authors:  Gustavo D Pimentel; Juliane Cs Zemdegs; Joyce A Theodoro; João F Mota
Journal:  Diabetol Metab Syndr       Date:  2009-09-16       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.